Johnson & Johnson's Animas diabetes unit mailed a letter to patients explaining a cyber security vulnerability in its Animas OneTouch Ping insulin pump. A hacker could potentially overdose diabetic patients with insulin, although the company says the hacking risk is low.
J&J executives told Reuters they knew of no examples of attempted attacks on the device, however, the company is still warning customers and giving them advice on how to fix the problem.
"The probability of unauthorized access to the OneTouch Ping system is extremely low," the company said in letters mailed out on Monday to doctors and about 114,000 patients in the United States and Canada who use the device. A copy of the text of the letter was made available to Reuters.
Read the full story